Phase I Safety Study of Inhaled N-IP-00001 to Determine Tolerability and Safety in Healthy Volunteers.
Clinical trial NCT06662019 · COMPLETED
Trial details
- NCT number
- NCT06662019
- Sponsor
- NeoTrials Pty Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-29
- Primary completion
- 2025-01-15
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.